BioCryst Announces Preliminary Full Year 2022 ORLADEYO® (berotralstat) Net Revenue and Provides Full Year 2023 ORLADEYO Net Revenue Guidance

January 9, 2023

https://www.globenewswire.com/news-release/2023/01/09/2585065/29446/en/BioCryst-Announces-Preliminary-Full-Year-2022-ORLADEYO-berotralstat-Net-Revenue-and-Provides-Full-Year-2023-ORLADEYO-Net-Revenue-Guidance.html

—ORLADEYO preliminary 2022 full year net revenue of $251.6 million (+105 percent y-o-y)—

—ORLADEYO net revenue expected to be no less than $320 million in 2023—

Read more at globenewswire.com

Related news for (BCRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.